A song on Neil Young's protest album, Living With War, asks whether the restless consumer will grow tired of Madison Avenue lies, including those Young attributes to the drug industry:
Don't need no TV ad
Tellin' me how sick I am
Don't want to know how many people are like me
Don't need no dizziness
Don't need no nausea
Don't need no side effects like diarrhea or sexual death
Even though the drug industry develops medicines that benefit millions of people, it ranks among the least trusted industries
in opinion polls of consumers. On a GfK NOP/Market Measures survey of 1,000 consumers conducted in March 2005, only 21 percent
gave the pharmaceutical industry a favorable rating. A Wall Street Journal/NBC News poll conducted in January 2005 found that only three percent of people polled believed that drug companies were
working for the public good; 76 percent said they were most interested in making a profit.
Arthur Lazarus, MD
If consumerism and patriotism stand opposite each other, as Young's song, "Restless Consumer," implies, I wonder whether working
in the pharmaceutical industry is offensive to Americans. To be sure, "Restless Consumer" also targets the American addiction
to oil and materialism, relating it not only to war but also to the greater failure to address problems of poverty. I'm particularly
sensitive to Young's lyrics about the industry, perhaps because I worked in managed care before I joined pharma. I feel vulnerable
to accusations that I work on the dark side, that I've sold out to corporate medicine.
Young's verse about pharmaceutical marketing also pains me because he has been one of my favorite rock artists for decades.
I own almost everything Neil Young ever released on vinyl, CD, laser disc, and DVD. I'm one of those balding 50-something
guys you see rocking out in a 12-speaker, Bose-equipped Infiniti-FX, sliding toward old age even as I take my 20-year-old
son to the opening-night concert of the Crosby, Stills, Nash and Young Freedom of Speech '06 tour (also dubbed "Soapbox '06"
by the tongue-in-cheek Young).
I don't feel as though I've committed any sins by working for Big Pharma, but I do recall reading confessional essays from
physicians who have worked in managed care, seeking forgiveness for repeatedly saying "no" to their colleagues: No, you can't
be reimbursed for this, and no, your patient cannot have that procedure. As a pharmaceutical physician, however, I don't feel
the need to apologize.
I'm involved in cutting-edge clinical trials. I help design care-management programs, primarily for patients with severe
and persistent mental illnesses. I also review marketing material for medical accuracy. Neil Young may have heard enough about
nausea and diarrhea on television, but accurately describing medication side effects is critically important for consumers.
FDA also requires this information as fair balance.
Making scientifically supportable product claims—and not misleading the public—is also important. In fact, the expertise of
pharmaceutical physicians helps create advertising and promotional material that is true to the medical and therapeutic realities
of treatment, which helps accurately convey beneficial outcomes.
The greatest compliment anyone ever paid me was calling me a double agent. The individual meant that, by working on the "inside,"
I probably have better opportunities to improve patient care than I would in private practice. I admit that healthcare administration
is an unconventional career path for a physician, but it can be rewarding, sometimes even redemptive. Neil Young is not the
only one who's seen the needle and the damage done.
Arthur Lazarus, MD, is senior director, clinical research, for AstraZeneca. He can be reached at firstname.lastname@example.org